Heron Files for Supplement for ZYNRELEF; Bill Seen to Provide Separate Reimbursement

 Supplemental New Drug Application Submitted Requesting Expansion of Indication to Broadly Cover Soft Tissue and Orthopedic Surgical Procedures -

- Omnibus Spending Bill (H.R. 2617) Includes Provision to Provide Separate Payments for Non-Opioid Treatment for Pain Relief in the Outpatient Setting Beginning January 1, 2025 -

https://finance.yahoo.com/news/heron-therapeutics-announces-filing-efficacy-140000391.html